NASDAQ:SNNA Sienna Biopharmaceuticals (SNNA) Stock Price, News & Analysis → Does this make you sick? (From Allegiance Gold) (Ad) Free SNNA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.11▼$0.1750-Day Range$0.14▼$0.1452-Week Range$0.06▼$3.80Volume13.32 million shsAverage Volume1.87 million shsMarket Capitalization$4.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Sienna Biopharmaceuticals alerts: Email Address Ad Daily Market AlertsTop 5 Tech Stocks to Buy for 2024Elon Musk just Triggered a BOOM in These Stocks Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk.Click here to sign up for our free report & newsletter About Sienna Biopharmaceuticals Stock (NASDAQ:SNNA)Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA.Read More Ad Daily Market AlertsTop 5 Tech Stocks to Buy for 2024Elon Musk just Triggered a BOOM in These Stocks Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk.Click here to sign up for our free report & newsletter SNNA Stock News HeadlinesMay 20 at 12:55 PM | msn.comBarrel Jeans Just Got The Sienna Miller Treatment At The Cannes Film FestivalMay 20 at 12:55 PM | msn.comInside the ultra-luxe Maldivian hotel where Sienna Miller babymooned: $3K-per-night villa, tree houses, hypnobirthing classesMay 20 at 12:55 PM | msn.comSienna Miller and Daughter Marlowe Have Sweet Red-Carpet Moment in CannesMay 20 at 12:55 PM | msn.comSienna Miller's Daughter Marlowe Sturridge Makes Cannes Red Carpet Debut for ‘Horizon' Premiere in Complementary Whimsical LookMay 20 at 7:55 AM | yahoo.comSienna Miller Says ‘Magical’ Babymoon Was Her 1st Vacation Ever With Boyfriend Oli GreenMay 20 at 7:55 AM | msn.comSienna Miller’s daughter Marlowe Sturridge makes her red-carpet debut at CannesMay 20 at 7:55 AM | msn.comSienna Miller walks the Cannes red carpet with daughter MarloweMay 20 at 7:55 AM | msn.comSienna Miller's rarely-seen daughter Marlowe, 11, models tumbling princess hair for red carpet appearanceMay 20 at 7:55 AM | mirror.co.ukSienna Miller makes first ever red carpet appearance with daughter Marlowe, 11, and they look so alikeMay 20 at 7:55 AM | msn.comSienna Miller Shares Inside Glimpse of Her ‘Babymoon’ in the Maldives: 'It Was Astounding'May 19 at 8:57 PM | msn.comSalma Hayek, Sienna Miller and Selena Gomez bring out the glamour for day 6 of Cannes Film Festival – see the photosMay 19 at 8:57 PM | msn.com‘Horizon’ Film Launch at 2024 Cannes: Kevin Costner & Sienna Miller Joined by Their Children | Cannes Film Festival 2024, Film Premieres, Kevin Costner Family, Sienna ...May 19 at 3:39 PM | forbes.com‘Horizon’: Kevin Costner And Sienna Miller Among Stars On Cannes Red CarpetMay 19 at 3:39 PM | msn.comSienna Miller Went From Topless Cowboy to Pantsless Cinderella on the Cannes Red CarpetMay 15, 2024 | finance.yahoo.comSienna Announces May DividendMay 13, 2024 | msn.comThe 2024 Toyota 4Runner vs. Toyota SiennaMay 11, 2024 | msn.comPoppy Delevingne dating Sienna Miller's exMay 8, 2024 | mirror.co.ukSienna Miller just stepped out in a spring-perfect trench coat from Victoria Beckham's Mango rangeMay 8, 2024 | msn.comSienna Miller Wore the Shoe Trend That's All Over Zara and Mango to the Met GalaMay 8, 2024 | msn.comSienna Miller Just Wore the Pretty Top-and-Jeans Combo That's So Summer 2024May 8, 2024 | msn.comSienna Miller’s Met Gala After Party Look Proves The Appeal Of Jeans And A Nice TopMay 8, 2024 | msn.comSienna Miller Wore the Shoe Trend That’s All Over Zara and Mango to the Met GalaMay 7, 2024 | msn.comSienna Miller’s Met Gala After Party Look Is Bringing Back Jeans And A Nice TopMay 7, 2024 | msn.comHow Sienna Miller's 'no make-up' make-up was achieved at the 2024 Met GalaMay 7, 2024 | msn.comWho Is Sienna Miller Dating? A Look at the Actress's Love LifeSee More Headlines Receive SNNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sienna Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/14/2019Today5/21/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:SNNA CUSIPN/A CIK1656328 Webwww.siennabio.com Phone(818) 629-2256FaxN/AEmployees39Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-73,470,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-177.36% Return on Assets-52.22% Debt Debt-to-Equity RatioN/A Current Ratio15.27 Quick Ratio15.27 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.27 per share Price / Book0.11Miscellaneous Outstanding Shares30,908,000Free FloatN/AMarket Cap$4.20 million OptionableNot Optionable Beta2.67 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesFrederick C. BeddingfieldPresident, Chief Executive Officer & DirectorMajed KheirVice President-OperationsPaul F. LizzulChief Medical OfficerSilvio TraversaChief Scientific OfficerTodd J. HarrisDirector & Head-Corporate DevelopmentKey CompetitorsAlzamend NeuroNASDAQ:ALZNExicureNASDAQ:XCURCyclacel PharmaceuticalsNASDAQ:CYCCPetros PharmaceuticalsNASDAQ:PTPITharimmuneNASDAQ:THARView All Competitors SNNA Stock Analysis - Frequently Asked Questions How were Sienna Biopharmaceuticals' earnings last quarter? Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) posted its quarterly earnings data on Thursday, March, 14th. The company reported ($0.93) EPS for the quarter, missing analysts' consensus estimates of ($0.83) by $0.10. What other stocks do shareholders of Sienna Biopharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sienna Biopharmaceuticals investors own include SCYNEXIS (SCYX), Allena Pharmaceuticals (ALNA), Spectrum Pharmaceuticals (SPPI), Selecta Biosciences (SELB), Viking Therapeutics (VKTX), Novavax (NVAX), Synergy Pharmaceuticals (SGYP), Zealand Pharma A/S (ZEAL) and Bausch Health Companies (BHC). When did Sienna Biopharmaceuticals IPO? Sienna Biopharmaceuticals (SNNA) raised $64 million in an initial public offering on Thursday, July 27th 2017. The company issued 4,300,000 shares at $14.00-$16.00 per share. J.P. Morgan, Cowen and BMO Capital Markets acted as the underwriters for the IPO. This page (NASDAQ:SNNA) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaTop 5 Tech Stocks to Buy for 2024Daily Market AlertsBill Gates is all about this tiny $2 stockTimothy SykesThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldNext President (Not Trump. Not Biden.)The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sienna Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.